NSRX CIK: 2029039

Nasus Pharma Ltd

  • Israel
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY22:
−1.96
FY23:
−1.03
FY24:
−0.67
FY25:
−4.92
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
−3.01
Change from FY22 to FY25
millions USD
FY22:
1.47
FY23:
1.06
FY24:
0.77
FY25:
8.92
millions USD
FY22:
–
FY23:
0.04
FY24:
0.10
FY25:
0.98
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
−4.93

All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data